Back to Search Start Over

Identification of certain Panax species to be potential substitutes for Panax notoginseng in hemostatic treatments

Authors :
Sze Chung Yuen
Guang Yi Fan
Siu Wai Leung
Bin Rui Yang
Simon Ming-Yuen Lee
Wei-hong Cong
Source :
Pharmacological Research. 134:1-15
Publication Year :
2018
Publisher :
Elsevier BV, 2018.

Abstract

Panax notoginseng (Burkill) F. H. Chen ex C. H. Chow (P. notoginseng) is a highly valued Chinese materia medica having a hemostatic effect and mainly used for the treatment of trauma and ischemic cardiovascular diseases. Stringent growth requirements, weak resistance to insect pests and plant diseases, arsenic contamination and continuous cropping constitute hurdles to further increases in the agricultural production of P. notoginseng. This review focuses on the traditional uses (based on traditional Chinese medicine theory), major chemical components, biological activities, pharmacological properties, geographical distributions and historical development of taxonomy of P. notoginseng and its related species in Panax genus, including Panax japonicus C. A. Meyer (P. japonicus), Panax japonicus C. A. Meyer var. major (Burkill) C. Y. Wu et K. M. Feng (P. japonicus var. major) and Panax japonicus C. A. Meyer var. bipinnatifidus (Seem.) C. Y. Wu et K. M. Feng (P. japonicus var. bipinnatifidus) are reviewed. This review sheds light on the origin herbs of Zhujieshen (ZJS) and Zhuzishen (ZZS), e.g., P. japonicas var japonicas, P. japonicus var. major and P. japonicus var. bipinnatifidus could be used as a substitute for P. notoginseng as hemostatic herbs.

Details

ISSN :
10436618
Volume :
134
Database :
OpenAIRE
Journal :
Pharmacological Research
Accession number :
edsair.doi.dedup.....ec30487bdee74ebd1efcd4bbe90db764
Full Text :
https://doi.org/10.1016/j.phrs.2018.05.005